Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)

Priya Rastogi, D. Lawrence Wickerham, Charles E. Geyer, Eleftherios P. Mamounas, Thomas B. Julian, Norman Wolmark

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.

Original languageEnglish (US)
Article number7
JournalChinese Clinical Oncology
Volume6
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Breast
Clinical Trials
Breast Neoplasms
Puerto Rico
Radiation Oncology
National Cancer Institute (U.S.)
Standard of Care
Group Psychotherapy
Canada
Radiotherapy
Randomized Controlled Trials
Organizations
Therapeutics

Keywords

  • Breast cancer
  • Clinical trials
  • Locoregional therapy for breast cancer
  • Systemic therapy for breast cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Rastogi, P., Wickerham, D. L., Geyer, C. E., Mamounas, E. P., Julian, T. B., & Wolmark, N. (2017). Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Chinese Clinical Oncology, 6(1), [7]. https://doi.org/10.21037/cco.2017.02.02

Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). / Rastogi, Priya; Wickerham, D. Lawrence; Geyer, Charles E.; Mamounas, Eleftherios P.; Julian, Thomas B.; Wolmark, Norman.

In: Chinese Clinical Oncology, Vol. 6, No. 1, 7, 2017.

Research output: Contribution to journalReview article

Rastogi, P, Wickerham, DL, Geyer, CE, Mamounas, EP, Julian, TB & Wolmark, N 2017, 'Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)', Chinese Clinical Oncology, vol. 6, no. 1, 7. https://doi.org/10.21037/cco.2017.02.02
Rastogi, Priya ; Wickerham, D. Lawrence ; Geyer, Charles E. ; Mamounas, Eleftherios P. ; Julian, Thomas B. ; Wolmark, Norman. / Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). In: Chinese Clinical Oncology. 2017 ; Vol. 6, No. 1.
@article{a6af0300cc444922af3e045b53cf4f1d,
title = "Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)",
abstract = "The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.",
keywords = "Breast cancer, Clinical trials, Locoregional therapy for breast cancer, Systemic therapy for breast cancer",
author = "Priya Rastogi and Wickerham, {D. Lawrence} and Geyer, {Charles E.} and Mamounas, {Eleftherios P.} and Julian, {Thomas B.} and Norman Wolmark",
year = "2017",
doi = "10.21037/cco.2017.02.02",
language = "English (US)",
volume = "6",
journal = "Chinese Clinical Oncology",
issn = "2304-3865",
publisher = "Society for Translational Medicine (STM)",
number = "1",

}

TY - JOUR

T1 - Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)

AU - Rastogi, Priya

AU - Wickerham, D. Lawrence

AU - Geyer, Charles E.

AU - Mamounas, Eleftherios P.

AU - Julian, Thomas B.

AU - Wolmark, Norman

PY - 2017

Y1 - 2017

N2 - The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.

AB - The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.

KW - Breast cancer

KW - Clinical trials

KW - Locoregional therapy for breast cancer

KW - Systemic therapy for breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85013393599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013393599&partnerID=8YFLogxK

U2 - 10.21037/cco.2017.02.02

DO - 10.21037/cco.2017.02.02

M3 - Review article

C2 - 28285537

AN - SCOPUS:85013393599

VL - 6

JO - Chinese Clinical Oncology

JF - Chinese Clinical Oncology

SN - 2304-3865

IS - 1

M1 - 7

ER -